BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Medicamen Organics Ltd. Share Price

NSE
BSE

NSE : MEDIORG

BSE : 0

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹25.00

High

₹26.00

Price Summary

Previous Close ₹26.00
Day's Range ₹25.00 - ₹26.00
Open ₹25.00
52 Week Range ₹19.10 - ₹45.00
Volume 54,000
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 14.04
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 0.00
TTM EPS (₹) -3.30
P/E Ratio 6.27
Book Value(₹) 1.02
PAT Margin (%) 10.60
Face Value (₹) 10.00
ROCE(%) 16.97

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales N/A 370.88
Expenses N/A N/A
PBT N/A 43.87
Operating profit N/A 0.0
Net profit N/A 32.71

Shareholding Pattern

Promoters (% Holding)

59.73%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.56%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.07%

About Medicamen Organics Ltd.

Founded 1995
Managing Director Bal Kishan Gupta
NSE Symbol MEDIORG

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,66,178.79 1,954.05 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,96,095.00 7,312.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,91,530.43 5,027.80 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,28,516.16 8,928.05 6,696.50 - 6,696.50
Cipla Ltd. 1,14,318.19 1,393.75 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,12,693.00 1,113.60 835.50 - 835.50
Lupin Ltd. 1,10,001.57 2,400.95 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 1,05,274.12 1,085.00 903.00 - 903.00
Mankind Pharma Ltd. 1,05,068.24 2,561.70 1,909.70 - 1,909.70
Dr. Reddy's Laboratories Ltd. 98,742.15 1,166.50 1,148.40 - 1,148.40
no-content No Records Found

Latest News

Jul
23
2026
EQUITY Posted on Jul 23rd 2026

Sanofi India informs about analyst meet

Sanofi India has informed that the Company will hold an investor / analysts call for an update on Unaudited Financial Results for the quarter and half year ended 30th June 2026, the details enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
23
2026
EQUITY Posted on Jul 23rd 2026

Cipla informs about press release

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it enclosed the Press Release for Q1FY27 financial results dated 23rd July, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
23
2026
EQUITY Posted on Jul 23rd 2026

Cipla informs about financial results

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that the Board of Directors of the Company at its meeting held today i.e., 23rd July, 2026, has approved the unaudited financial results (standalone and consolidated) for the quarter ended 30th June, 2026. In this regard, it has enclosed the following for the quarter ended 30th June, 2026: Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards; and Limited review report (standalone and consolidated) issued by BSR & Co. LLP, Statutory Auditors of the Company. The Board meeting of the Company commenced today at 09:15 am (IST) and is still in progress. The conclusion time of meeting will be separately intimated to the Stock Exchanges upon completion of proceedings. The above-mentioned documents will also be available on the Company’s website www.cipla.com in the Investors Section.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
23
2026
EQUITY Posted on Jul 23rd 2026

Sanofi India informs about resignation of director

Pursuant to Regulation 30 of the Listing Regulations, Sanofi India has informed that Rachid Ayari (DIN:10408699) vide his letter dated 22nd July 2026, had conveyed his decision to step down from his current role as the Whole Time Director, Chief Financial Officer and Key Managerial Personnel of the Company with effect from the close of business hours on 30th September 2026, in view of his transition to another role within the Sanofi group. Accordingly, Rachid Ayari shall cease to be the Whole Time Director, Chief Financial Officer, Key Managerial Personnel and shall also cease to be Senior Management Personnel and member of the Risk Management Committee effective from the close of business hours on 30th September 2026. The Company places on record its sincere appreciation to Rachid Ayari for his valuable contributions, expert guidance, and dedicated assistance provided during his tenure with the Company. The Company is in the process of identifying a suitable candidate for the position of Chief Financial Officer, who will also be designated as a Key Managerial Personnel. The Company will inform the Stock Exchanges of the appointment in due course. The information required in terms of Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 is enclosed as ‘Annexure-I’ and letter received from Rachid Ayari is enclosed as ‘Annexure – II’.

The above information is a part of company’s filings submitted to BSE.
Read More
Jul
23
2026
EQUITY Posted on Jul 23rd 2026

Supriya Lifescience informs about newspaper advertisement

In terms of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed copies of the newspaper advertisement extract for Postal Ballot Notice published in the newspapers, Financial Express (English Language) and Loksatta (Marathi Language).
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Medicamen Organics Ltd. ?

The current share price of Medicamen Organics Ltd. is ₹26.00 as of 2026-07-23.

The market capitalisation of Medicamen Organics Ltd. is ₹30.41 as of 2026-07-22.

The 1-year return of Medicamen Organics Ltd. is -12.05% as of 2026-07-23.

The P/E ratio of Medicamen Organics Ltd. is 6.27 as of 2026-07-23.

The 52-week high and low of Medicamen Organics Ltd. are ₹45.00 and ₹19.10, respectively, as of 2026-07-23.

The dividend yield of Medicamen Organics Ltd. is 0.0% as of2026-07-22.

You can buy Medicamen Organics Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Medicamen Organics Ltd. is Bal Kishan Gupta.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore